Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02363803 · ClinicalTrials.gov registry record · NA
Lidocaine for Diabetic Peripheral Neuropathy
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT02363803 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 34 participants.
The verdict
NCT02363803, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
Diabetic nerve pain \[painful diabetic peripheral neuropathy\] is a common medical problem with few reliably effective treatments. There is some evidence that sensory testing may help determine how individuals will respond to analgesic therapy. In this study, the investigators are evaluating the relationship between sensory testing and subject response to lidocaine infusion therapy.
Interventions
- DRUG Placebo
- DRUG lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2015-02 |
| Est. Completion | 2018-10-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02363803
The ClinicalTrials.gov registry entry for NCT02363803 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02363803 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02363803 about?
NCT02363803 is a clinical study titled "Lidocaine for Diabetic Peripheral Neuropathy". Diabetic nerve pain \[painful diabetic peripheral neuropathy\] is a common medical problem with few reliably effective treatments. There is some evidence that sensory testing may help determine how individuals will respond to analgesic therapy. In this study, the investigators are evaluating the rel...
What is the current status of trial NCT02363803?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2015-02. Estimated completion is 2018-10-17.
What interventions are being tested in trial NCT02363803?
The interventions under investigation include: Placebo (DRUG), lidocaine (DRUG).
Who is sponsoring clinical trial NCT02363803?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.